Growth Metrics

OptimizeRx (OPRX) Cash from Investing Activities (2016 - 2026)

OptimizeRx's Cash from Investing Activities history spans 16 years, with the latest figure at $206000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 271.67% to $206000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $68000.0, a 115.11% increase, with the full-year FY2025 number at $68000.0, up 115.11% from a year prior.
  • Cash from Investing Activities hit $206000.0 in Q4 2025 for OptimizeRx, up from -$10000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for OPRX hit a ceiling of $3.2 million in Q2 2023 and a floor of -$37.5 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$4.2 million across 5 years, with a median of -$109510.5 in 2021.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 22425.43% in 2022 and later surged 271.67% in 2025.
  • Tracing OPRX's Cash from Investing Activities over 5 years: stood at -$99021.0 in 2021, then plummeted by 18567.26% to -$18.5 million in 2022, then plummeted by 40.66% to -$26.0 million in 2023, then skyrocketed by 99.54% to -$120000.0 in 2024, then surged by 271.67% to $206000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for OPRX at $206000.0 in Q4 2025, -$10000.0 in Q3 2025, and -$44000.0 in Q2 2025.